Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2025-12-27 @ 10:38 PM
Study NCT ID:
NCT04516161
Status:
COMPLETED
Last Update Posted:
2022-03-31
First Post:
2020-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-27
First Submit QC Date:
None
Study First Post Date:
2020-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-17
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL